Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -232.13% is 66% above its 5-year average of -680.00%, near the high end of its 5-year range (-133133.33%–-37.46%).
58.21% above its 12-month average of -555.46%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -152.55%.
EBITDA MARGIN
-232.13%
EBITDA MARGIN AVG TTM
-555.46%
EBITDA MARGIN AVG 3Y
-694.21%
EBITDA MARGIN AVG 5Y
-680.00%
EBITDA MARGIN AVG 10Y
-715.34%
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+58.21%
CURRENT VS 3Y AVG
+66.56%
CURRENT VS 5Y AVG
+65.86%
CURRENT VS 10Y AVG
+67.55%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Editas Medicine, Inc.
Market Cap
$432.00M
EBITDA Margin
-232.13%
TTM Avg
-555.46%
3Y Avg
-694.21%
5Y Avg
-680.00%
Market Cap
$434.84M
EBITDA Margin
-184.73%
TTM Avg
-138.06%
3Y Avg
-2467.18%
5Y Avg
-2497.88%
Market Cap
$443.61M
EBITDA Margin
-16.58%
TTM Avg
-87.69%
3Y Avg
-357.20%
5Y Avg
-653.36%
Market Cap
$412.76M
EBITDA Margin
-59.97%
TTM Avg
-74.12%
3Y Avg
-94.06%
5Y Avg
-94.06%
Market Cap
$412.14M
EBITDA Margin
39.39%
TTM Avg
8.38%
3Y Avg
8.38%
5Y Avg
8.38%
Market Cap
$411.45M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$408.54M
EBITDA Margin
-48.80%
TTM Avg
-44.09%
3Y Avg
-45.35%
5Y Avg
-45.35%
Market Cap
$457.20M
EBITDA Margin
-1349.20%
TTM Avg
-1349.20%
3Y Avg
-1349.20%
5Y Avg
-1349.20%
Market Cap
$460.20M
EBITDA Margin
0.24%
TTM Avg
-1.36%
3Y Avg
-6.49%
5Y Avg
-5.53%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | $432.00M | -232.13% | -555.46% | -694.21% | -680.00% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $434.84M | -184.73% | -138.06% | -2467.18% | -2497.88% |
| Assembly Biosciences, Inc. (ASMB)vs › | $443.61M | -16.58% | -87.69% | -357.20% | -653.36% |
| Carlsmed, Inc. (CARL)vs › | $412.76M | -59.97% | -74.12% | -94.06% | -94.06% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $412.14M | 39.39% | 8.38% | 8.38% | 8.38% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $411.45M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $408.54M | -48.80% | -44.09% | -45.35% | -45.35% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $457.20M | -1349.20% | -1349.20% | -1349.20% | -1349.20% |
| NeoGenomics, Inc. (NEO)vs › | $460.20M | 0.24% | -1.36% | -6.49% | -5.53% |
| Kamada Ltd. (KMDA)vs › | $460.98M | 22.80% | 21.92% | 17.96% | 15.83% |
Gross Margin
100.0%
EBITDA Margin
-232.1%
Operating Margin
-245.2%
Net Margin
-157.3%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -152.55% |
| 2026-03-31 | -866.13% |
| 2025-12-31 | -53.40% |
| 2025-09-30 | -315.88% |
| 2025-06-30 | -1389.32% |
| 2025-03-31 | -1593.95% |
| 2024-12-31 | -147.73% |
| 2024-09-30 | -105027.87% |
| 2024-06-30 | -13739.38% |
| 2024-03-31 | -5778.15% |
| 2023-12-31 | -37.46% |
| 2023-09-30 | -911.71% |
| 2023-06-30 | -1473.99% |
| 2023-03-31 | -501.64% |
| 2022-12-31 | -946.59% |
| 2022-09-30 | -133133.33% |
| 2022-06-30 | -827.35% |
| 2022-03-31 | -726.51% |
| 2021-12-31 | -321.59% |
| 2021-09-30 | -614.22% |
| 2021-06-30 | -14303.96% |
| 2021-03-31 | -857.36% |
| 2020-12-31 | -566.50% |
| 2020-09-30 | 16.07% |
| 2020-06-30 | -283.45% |
| 2020-03-31 | -800.59% |
| 2019-12-31 | -314.56% |
| 2019-09-30 | -879.96% |
| 2019-06-30 | -1500.26% |
| 2019-03-31 | -1480.62% |
| 2018-12-31 | -414.66% |
| 2018-09-30 | -106.20% |
| 2018-06-30 | -527.31% |
| 2018-03-31 | -784.52% |
| 2017-12-31 | -974.23% |
| 2017-09-30 | -414.92% |
| 2017-06-30 | -822.22% |
| 2017-03-31 | -4398.24% |
| 2016-12-31 | -4286.86% |
| 2016-09-30 | -2170.89% |
| 2016-06-30 | -559.45% |
| 2016-03-31 | -2192.80% |
| 2015-12-31 | -1543.56% |
| 2015-09-30 | -1082.09% |
| 2015-06-30 | -6160.48% |
